Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC
- 7 May 2026
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 489 (3) , 1-5
Abstract
Renal cell carcinoma associated with anaplastic lymphoma kinase rearrangement (ALK-RCC) is a rare subtype within the category of molecularly defined renal cell carcinomas. Due to its low incidence and highly heterogeneous clinicopathological features, ALK-RCC poses a significant diagnostic challenge. The implementation of advanced molecular techniques has facilitated the identification of various fusion partners, which may influence clinical behavior and guide targeted therapies. We report a case of ALK-RCC harboring a novel fusion partner, RAB1A::ALK. This report describes the clinicopathological and molecular features of the tumor, with a particular focus on the characterization of the RAB1A gene and its documented impact on carcinogenesis and prognosis across several solid malignancies. Our findings expand the molecular spectrum of ALK-RCC and emphasize the role of comprehensive molecular profiling in uropathology.Keywords
This publication has 14 references indexed in Scilit:
- ALK-Rearranged renal neoplasms: update on an institutional cohortVirchows Archiv, 2025
- ALK-Rearranged Renal Cell Carcinoma: A Study of Three Cases With Clinicopathologic Features and Effect of Postoperative Adjuvant ImmunotherapyClinical Genitourinary Cancer, 2024
- ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic SpectrumLaboratory Investigation, 2024
- VCL-ALK renal cell carcinoma in adult patient without sickle cell traitHuman Pathology: Case Reports, 2021
- ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217Laboratory Investigation, 2020
- Responses to Alectinib in ALK-rearranged Papillary Renal Cell CarcinomaEuropean Urology, 2018
- The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testingCancer, 2018
- ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature reviewCancer Genetics, 2018
- Mechanistic insight into ALK receptor tyrosine kinase in human cancer biologyNature Reviews Cancer, 2013
- Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrumLaboratory Investigation, 2011